Follow:
RSS
Email
Twitter
Curaxis Pharmaceutical Corp. :: Alzheimer's News, Insight, and Information
  • Home
  • About Us
  • Media
  • Uncategorized

Archive for February, 2010

  • Damaged Protein May Predict Alzheimer’s on February 25th, 2010
  • Inadequate Vision in Elderly Linked to Alzheimer’s on February 22nd, 2010
  • Sex hormone link to poorer memory in men on February 18th, 2010
  • Curaxis Debuts New Video on February 12th, 2010
  • Marijuana doesn’t help Alzheimer’s disease according to study on February 10th, 2010
  • Smoking May Create an Added Risk for Alzheimer’s Disease on February 8th, 2010
  • Three Brain Diseases Linked by Toxic Form of Same Neural Protein on February 3rd, 2010
  • Fish oil shows promise in preventing psychosis on February 3rd, 2010

  • Recent Articles

    • Spinal taps may be useful in predicting brain disorders
    • New Study Explores Link Between Type 2 Diabetes, Alzheimer’s
    • Alzheimer’s drug could put the brakes on deadly disease
    • New Alzheimer’s test
    • Study finds stress may increase Alzheimer’s risk
  • Categories

  • Archives

    • August 2010 (11)
    • July 2010 (17)
    • June 2010 (20)
    • May 2010 (20)
    • April 2010 (19)
    • March 2010 (16)
    • February 2010 (8)
    • January 2010 (16)
    • December 2009 (17)
    • November 2009 (1)
  • Curaxis Pharmaceutical Corp.

    Curaxis Pharmaceutical Corporation is a specialty company dedicated to finding cures for major age-related diseases with it initial focus is Alzheimer’s Disease (or AD). For more, visit www.curaxispharma.com

  • Follow Us On Twitter

    • News:: New Study Explores Link Between Type 2 Diabetes, Alzheimer's http://bit.ly/bDgU67
    • News:: Alzheimer's drug could put the brakes on deadly disease http://bit.ly/dgEAY0
    • News:: New Alzheimer's test http://blog.curaxispharma.com/2010/08/17/new-alzheimers-test/

About

Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Our initial focus is Alzheimer’s Disease (or AD). Our lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer’s Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease.
  • Videos

Search

Copyright © 2010 Curaxis Pharmaceutical Corp.